Fibrodysplasia ossificans progressiva

FOP · Rare Disease · 1 drugs · 1 indications

Competitive Landscape (1 drugs)

Drug	Company	Mechanism	Modality	Route	Stage
Garetosmab	REGN	Activin A inhibitor (monoclonal antibody)	Monoclonal antibody	IV	PHASE3

Indications (1)

Data from Supabase · Updated 2026-03-24